Ana Rio-Machin
15PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Apr 09, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.Fadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen
|Aug 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.Vilma Dembitz, Hannah Lawson, Richard Burt
|Feb 27, 2023
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.Pedro Casado, Ana Rio-Machin, Juho J Miettinen
|Dec 09, 2022
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes.Nerea Berastegui, Marina Ainciburu, Juan P Romero
|Sep 26, 2022
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment.Hannah Armes, Findlay Bewicke-Copley, Ana Rio-Machin
Pageof 3
Frequent Collaborators
7 joint publications
Findlay Bewicke-Copley
7 joint publications
Jude Fitzgibbon
6 joint publications
Kevin Rouault-Pierre
4 joint publications
Pedro R Cutillas
4 joint publications
Pedro Casado
3 joint publications
Juho J Miettinen
3 joint publications
Céline Philippe
3 joint publications
Szilvia Krizsán
3 joint publications
Caroline Heckman
2 joint publications
Jun Wang
